Literature DB >> 11557283

Effect of morphine on caloric intake and macronutrient selection in male and female Lou/c/jall rats during ageing.

S Boghossian1, D Jourdan, M Dacher, J Alliot.   

Abstract

Previous studies have showed a shift of preferences from carbohydrate to fat in the Lou/c/jall rat with advancing age when they are submitted to a self-selection procedure. Protein intake also decreased according to the age, earlier for males (after 16 months) than for females (29 months). The present study aimed at investigating the mechanism underlying these modifications. We analysed the effect of the reference mu agonist, morphine (5 mg/kg subcutaneous), on the caloric intake, body weight and macronutrient intake of 30 male and 30 female rats divided in four age groups: young adults (10), mature (17), old (24) and senescent rats (29 months). During the experiment, animals had the choice between separate sources of the three pure macronutrients. Morphine injection reduced total daily caloric intake and induced a decrease in body weight. The weight loss was age- and sex-related (males and old rats were more affected by the drugs). The injection of morphine evoked a triphasic influence on the chronology of the intake. A brief (1 h) hypophagia was followed by an hyperphagia (3 h) and a persistent hypophagia (8 h). No modification in the diet composition was observed. These results did not support a clear involvement of the opioid system concerning the modifications in macronutrient rates in diet previously observed across ageing.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557283     DOI: 10.1016/s0047-6374(01)00321-9

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  1 in total

1.  Impact of ageing on the antinociceptive effect of reference analgesics in the Lou/c rat.

Authors:  Didier Jourdan; Gisèle Pickering; Fabien Marchand; Jean-Michel Gaulier; Josette Alliot; Alain Eschalier
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.